That's interesting, Credit Suisse saying A2 is losing stage 1 market share.....
A2 annual reports says "Sales of a2 至初® China label infant nutrition of $389.9 million, up 15.4%" & " Overall infant nutrition market in China decreased in volume1 during FY21 driven by a significant reduction in birth rates, particularly impacting early stage products, partially offset by increased product penetration"
mmm wouldn't have anything to do with potentially Credit Suisse being the bank/advisor of another Swiss coy would it?
Media Updates, page-9994
-
- There are more pages in this discussion • 4,871 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.36 |
Change
-0.125(2.28%) |
Mkt cap ! $3.935B | |||
| Open | High | Low | Value | Volume |
| $5.46 | $5.50 | $5.34 | $10.30M | 1.904M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 13764 | $5.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.36 | 5657 | 6 |
View Market Depth
| Last trade - 15.54pm 06/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |